Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Castiglione-Gertsch

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
The choice of systemic adjuvant therapy in receptor-positive early breast cancerSilvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|September 1, 2005
Ovarian ablation, a perennial technique still not well understoodSilvia Dellapasqua, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and notSilvia Dellapasqua, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancerAlexandre Bodmer, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|December 9, 2003
Adjuvant endocrine therapy for the very young patientsStefan Aebi, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Why did the study fail?Silvia Dellapasqua, Monica Castiglione-Gertsch
Women'S Health (London, England)|October 7, 2009
Leukemia risk after adjuvant treatment of early breast cancerAlessandra Balduzzi, Monica Castiglione-Gertsch
Drugs|November 7, 2007
Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancerChrista K Baumann, Monica Castiglione-Gertsch
The Lancet. Oncology|October 5, 2007
Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conferenceManuela Rabaglio, Stefan Aebi, Monica Castiglione-Gertsch
Revue Medicale Suisse|June 28, 2012
[Breast cancer and obesity, a dangerous relation]Khalil Zaman, Alexandre Bodmer, François Pralong, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
The choice of systemic adjuvant therapy in receptor-positive early breast cancerSilvia Dellapasqua, Monica Castiglione-Gertsch
Nature Clinical Practice. Oncology|September 1, 2005
Ovarian ablation, a perennial technique still not well understoodSilvia Dellapasqua, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant endocrine therapies for postmenopausal women with early breast cancer: standards and notSilvia Dellapasqua, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancerAlexandre Bodmer, Monica Castiglione-Gertsch
Breast (Edinburgh, Scotland)|December 9, 2003
Adjuvant endocrine therapy for the very young patientsStefan Aebi, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|October 29, 2005
Why did the study fail?Silvia Dellapasqua, Monica Castiglione-Gertsch
Women'S Health (London, England)|October 7, 2009
Leukemia risk after adjuvant treatment of early breast cancerAlessandra Balduzzi, Monica Castiglione-Gertsch
Drugs|November 7, 2007
Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancerChrista K Baumann, Monica Castiglione-Gertsch
The Lancet. Oncology|October 5, 2007
Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conferenceManuela Rabaglio, Stefan Aebi, Monica Castiglione-Gertsch
Revue Medicale Suisse|June 28, 2012
[Breast cancer and obesity, a dangerous relation]Khalil Zaman, Alexandre Bodmer, François Pralong, et al.
Pageof 6